Interpace Biosciences Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 1997
Net Income	0.8	-5.87	-14.75	-26.2	-26.64	-12.19	-12.22	-8.33	-11.36	-16.07	Upgrade
Depreciation & Amortization	1.03	2.56	5.37	5.5	4.19	3.46	3.69	4.48	5.03	2.39	Upgrade
Share-Based Compensation	0.63	1.3	1.37	2.19	1.54	2.27	1.28	0.13	4.02	2.12	Upgrade
Other Operating Activities	1.33	-5.69	-0.72	3.93	1.96	-2.22	-8.01	-5.22	-17.53	-4.82	Upgrade
Operating Cash Flow	3.79	-7.69	-8.72	-14.58	-18.96	-8.67	-15.26	-8.94	-19.84	-16.38	Upgrade
Capital Expenditures	-0.47	-0.32	-0.35	-1.58	-0.13	-0.45	-0.03	0	-0.35	-11.35	Upgrade
Acquisitions	0.38	6.53	0.04	0	-13.83	0	0	0	0	-13.36	Upgrade
Change in Investments	-	-	-	-	-	-	-	-	-	-9.16	Upgrade
Other Investing Activities	-	-	-	-	0.01	-	-	-	26.75	8.5	Upgrade
Investing Cash Flow	-0.09	6.21	-0.32	-1.58	-13.95	-0.45	-0.03	0	26.4	-25.37	Upgrade
Dividends Paid	0	-3	0	0	0	0	0	0	0	0	Upgrade
Common Stock Issued	0	0.11	0.34	0.43	6.48	0	23.08	1.71	0.45	0	Upgrade
Share Repurchases	-0.03	-0.11	0	-0.05	-0.04	-0.01	-0.03	0	-0.21	-0.23	Upgrade
Other Financing Activities	-5.06	5.78	8.64	16.12	22.64	-0.02	6.78	-0.48	-22.02	18.99	Upgrade
Financing Cash Flow	-5.03	3	8.98	16.61	29.16	-0.01	29.89	1.23	-21.36	19.22	Upgrade
Net Cash Flow	-1.83	1.51	-0.06	0.45	-3.75	-9.13	14.6	-7.71	-14.8	-22.53	Upgrade
Free Cash Flow	3.32	-8.01	-9.07	-16.15	-19.09	-9.12	-15.29	-8.94	-20.2	-27.73	Upgrade
Free Cash Flow Margin	8.25%	-25.17%	-21.96%	-49.86%	-79.27%	-41.66%	-96.19%	-68.32%	-214.11%	-23.12%	Upgrade
Free Cash Flow Per Share	0.76	-1.89	-2.19	-4.01	-5.10	-3.24	-9.70	-49.23	-130.46	-186.09	Upgrade

Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.